Formulary Management for Targeted Immunomodulatory Biologics
This document summarizes decisions regarding Targeted Immunomodulatory Biologics on the TRICARE formulary
Change Healthcare Cyberattack Impact on MHS Pharmacy Operations. Read the statement to learn more.
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
You are leaving Health.mil View the external links disclaimer.